ARCHIVES

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 17 | April 29, 1994

Download PDF Visit The Full Archive

Related Articles

Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment

June 1, 2001

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

January 25, 2013

Funds Earmarked From NCI Budget for Action Plan

October 24, 1996

Braun Named Executive Director Of ASCO Foundation

November 17, 2006

Neutron Therapy Contracts Wind Down Next Year; DCT To Consider Whether To Continue Support

March 25, 1988